{
 "as_of": "2026-11-08",
 "cmr": "us-cm-kg/NASDAQ/SKYE",
 "fence": "The page is the record's research on the issuer — no analyst, no rating, no view.",
 "markdown": "The page is the record's research on the issuer — no analyst, no rating, no view.\n\n# Skye Bioscience, Inc. (NASDAQ: SKYE) — research page\n\nAs of 2026-11-08 · us-cm-kg · record version 1\n\n## Identity and listing\n\nThe issuer is Skye Bioscience, Inc., listed on NASDAQ under the ticker SKYE. Its ISIN is not on the record and its LEI is not on the record. Its security type is Corporate, its sector is 2834 Pharmaceutical Preparations, and its jurisdiction is the United States, Nevada. Its segment is not on the record. Its status is listed, not halted.\n\n## The disclosure read\n\nThe record holds 64 filings across 30 filing days in the window 2025-11-08 to 2026-11-08. The median gap between filing days is 8 days. The median latency is 11 days from the latest filing to the record date of 2026-11-08. The latest filing is dated 2026-10-28 and is of type regulatory_filing. The NASDAQ median is 6.0 days for cadence, 52 filings and 5.0 days for latency across 4,359 issuers. The sector median is 6.0 days for cadence, 63.0 filings and 4.0 days for latency across 526 issuers.\n\n## Auditor\n\nThe auditor of record is CBIZ CPAs P.C., located in Morristown, New Jersey. The record holds no auditor changes.\n\n## Events and halts\n\nThe record holds no listing, delisting or name change lines. The domicile change is not on the record, because EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, because the exchanges' tier transfers are not EDGAR filings. The halt flag reads listed, not halted.\n\n## Orderability\n\nThe outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.\n\n## Coverage\n\nThe record names 8 research houses on the issuer's investor-relations page: Cantor Fitzgerald, Citizens JMP, Craig-Hallum Capital Group, Evercore ISI, H.C. Wainwright & Co., Oppenheimer & Co., Piper Sandler and William Blair.\n\n## Open research\n\nNo openly published research notes were found on the record.\n\n## Licensed\n\nLicensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.\n\n## As-of depth\n\nThe sealed years that hold the issuer are 2021, 2022, 2023, 2024, 2025 and 2026. The earliest sealed date of the market is 2021-01-04. The live record began on 2026-09-12.\n\n## Sources\n\n8 source pages are named on this page; every value above carries its own source page and read date in the numbers.\n\n- https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)\n- https://data.sec.gov/submissions/CIK0001516551.json (identity.jurisdiction)\n- https://mcp.us-cm-kg.ai/events/NASDAQ/SKYE (the disclosure lines)\n- https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)\n- https://www.sec.gov/Archives/edgar/data/1516551/000162828026016394/skye-20251231.htm (the auditor)\n- https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)\n- https://ir.skyebioscience.com/stock-data/analyst-coverage (coverage)\n- https://mcp.us-cm-kg.ai/record/NASDAQ/SKYE (the record)\n",
 "market": "US",
 "node": "us-cm-kg",
 "numbers": {
  "as_of_depth": {
   "issuer_years_sealed": [
    "2021",
    "2022",
    "2023",
    "2024",
    "2025",
    "2026"
   ],
   "live_record_began": "2026-09-12",
   "node_history_from": "2021-01-04",
   "node_years_sealed": [
    "2021",
    "2022",
    "2023",
    "2024",
    "2025",
    "2026"
   ],
   "record_version": 1,
   "sealed": true
  },
  "auditor": {
   "auditor": {
    "read_by": "EDGAR 10-K cover page iXBRL tag (dei:AuditorName, dei:AuditorLocation, dei:AuditorFirmId, dei:DocumentPeriodEndDate)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://www.sec.gov/Archives/edgar/data/1516551/000162828026016394/skye-20251231.htm",
    "state": "sourced",
    "value": "CBIZ CPAs P.C."
   },
   "auditor_firm_id": {
    "read_by": "EDGAR 10-K cover page iXBRL tag (dei:AuditorName, dei:AuditorLocation, dei:AuditorFirmId, dei:DocumentPeriodEndDate)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://www.sec.gov/Archives/edgar/data/1516551/000162828026016394/skye-20251231.htm",
    "state": "sourced",
    "value": "199"
   },
   "auditor_location": {
    "read_by": "EDGAR 10-K cover page iXBRL tag (dei:AuditorName, dei:AuditorLocation, dei:AuditorFirmId, dei:DocumentPeriodEndDate)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://www.sec.gov/Archives/edgar/data/1516551/000162828026016394/skye-20251231.htm",
    "state": "sourced",
    "value": "Morristown, New Jersey"
   },
   "changes": []
  },
  "cmr": "us-cm-kg/NASDAQ/SKYE",
  "coverage": {
   "count": 8,
   "houses": [
    {
     "analyst": "Kristen Kluska",
     "house": "Cantor Fitzgerald",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://ir.skyebioscience.com/stock-data/analyst-coverage",
     "state": "sourced"
    },
    {
     "analyst": "Jonathan Wolleben",
     "house": "Citizens JMP",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://ir.skyebioscience.com/stock-data/analyst-coverage",
     "state": "sourced"
    },
    {
     "analyst": "Albert G Lowe, Ph.D.",
     "house": "Craig-Hallum Capital Group",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://ir.skyebioscience.com/stock-data/analyst-coverage",
     "state": "sourced"
    },
    {
     "analyst": "Michael DiFiore, Pharm.D.",
     "house": "Evercore ISI",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://ir.skyebioscience.com/stock-data/analyst-coverage",
     "state": "sourced"
    },
    {
     "analyst": "Ananda Ghosh, Ph.D.",
     "house": "H.C. Wainwright & Co.",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://ir.skyebioscience.com/stock-data/analyst-coverage",
     "state": "sourced"
    },
    {
     "analyst": "Jay Olson",
     "house": "Oppenheimer & Co.",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://ir.skyebioscience.com/stock-data/analyst-coverage",
     "state": "sourced"
    },
    {
     "analyst": "Ted Tenthoff",
     "house": "Piper Sandler",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://ir.skyebioscience.com/stock-data/analyst-coverage",
     "state": "sourced"
    },
    {
     "analyst": "Andy Hsieh, Ph.D.",
     "house": "William Blair",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-11",
     "source": "https://ir.skyebioscience.com/stock-data/analyst-coverage",
     "state": "sourced"
    }
   ],
   "pages_checked": [
    {
     "page": "https://ir.skyebioscience.com/stock-data/analyst-coverage",
     "result": "read: 8 of 16 named houses found on the page"
    }
   ],
   "read_by": "Perplexity sonar (search) · page read by this rail",
   "read_date": "2026-11-11",
   "since": "not stated on the page read",
   "state": "found"
  },
  "disclosure": {
   "against": {
    "exchange": {
     "issuers": 4359,
     "median_cadence_gap_days": 6,
     "median_filings": 52,
     "median_latency_days": 5,
     "name": "NASDAQ"
    },
    "sector": {
     "issuers": 526,
     "median_cadence_gap_days": 6,
     "median_filings": 63,
     "median_latency_days": 4,
     "name": "2834 Pharmaceutical Preparations"
    }
   },
   "by_type": {
    "ad_hoc": 1,
    "agm_egm": 9,
    "corporate_news": 5,
    "director_change": 4,
    "directors_dealings": 27,
    "halt_suspension": 3,
    "regulatory_filing": 9,
    "results": 6
   },
   "cadence_median_gap_days": 8,
   "filing_days": 30,
   "filings": 64,
   "latency_days": 11,
   "latest": [
    {
     "category": "PRER14A",
     "date": "2026-10-28",
     "source": "https://www.sec.gov/Archives/edgar/data/1516551/000162828026067744/skye20261027-preliminarypr.htm",
     "title": "PRER14A — PRER14A",
     "type": "regulatory_filing"
    },
    {
     "category": "PREM14A",
     "date": "2026-10-26",
     "source": "https://www.sec.gov/Archives/edgar/data/1516551/000162828026067322/skye20261023-preliminarypr.htm",
     "title": "PREM14A — PREM14A",
     "type": "regulatory_filing"
    },
    {
     "category": "SCHEDULE 13G",
     "date": "2026-10-14",
     "source": "https://www.sec.gov/Archives/edgar/data/1516551/000121465926012924/xslSCHEDULE_13G_X02/primary_doc.xml",
     "title": "SCHEDULE 13G",
     "type": "regulatory_filing"
    },
    {
     "category": "SCHEDULE 13D/A",
     "date": "2026-09-24",
     "source": "https://www.sec.gov/Archives/edgar/data/1516551/000187354526000009/xslSCHEDULE_13D_X02/primary_doc.xml",
     "title": "SCHEDULE 13D/A",
     "type": "regulatory_filing"
    },
    {
     "category": "4",
     "date": "2026-09-24",
     "source": "https://www.sec.gov/Archives/edgar/data/1516551/000159854926000015/xslF345X06/form4-09242026_080953.xml",
     "title": "4",
     "type": "directors_dealings"
    }
   ],
   "latest_filing_date": "2026-10-28",
   "read": "the node's event lines (list_events_since), as get_filings serves them",
   "source": "https://mcp.us-cm-kg.ai/events/NASDAQ/SKYE",
   "window": {
    "from": "2025-11-08",
    "to": "2026-11-08"
   }
  },
  "identity": {
   "exchange": {
    "read_by": "EDGAR company_tickers_exchange.json (SEC list of exchange-listed filers)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://www.sec.gov/files/company_tickers_exchange.json",
    "state": "sourced",
    "value": "NASDAQ"
   },
   "isin": {
    "market": "US",
    "reason": "no LEI, so no GLEIF ISIN route; EDGAR carries no ISIN",
    "state": "not_on_record"
   },
   "jurisdiction": {
    "read_by": "EDGAR submissions API (issuer header as filed) (stateOfIncorporation)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://data.sec.gov/submissions/CIK0001516551.json",
    "state": "sourced",
    "value": "United States — Nevada"
   },
   "lei": {
    "market": "US",
    "reason": "no GLEIF record with the exact legal name in jurisdiction US-NV",
    "state": "not_on_record"
   },
   "name": {
    "read_by": "EDGAR submissions API (issuer header as filed)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://data.sec.gov/submissions/CIK0001516551.json",
    "state": "sourced",
    "value": "Skye Bioscience, Inc."
   },
   "sector": {
    "read_by": "EDGAR submissions API (issuer header as filed) (SIC code as assigned by the SEC)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://data.sec.gov/submissions/CIK0001516551.json",
    "state": "sourced",
    "value": "2834 Pharmaceutical Preparations"
   },
   "security_type": {
    "read_by": "EDGAR submissions API (issuer header as filed)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://data.sec.gov/submissions/CIK0001516551.json",
    "state": "sourced",
    "value": "Corporate"
   },
   "segment": {
    "market": "US",
    "state": "not_on_record"
   },
   "ticker": {
    "read_by": "EDGAR company_tickers_exchange.json (SEC list of exchange-listed filers)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://www.sec.gov/files/company_tickers_exchange.json",
    "state": "sourced",
    "value": "SKYE"
   },
   "website": {
    "market": "US",
    "state": "not_on_record"
   }
  },
  "licensed": {
   "columns": [
    "licensor",
    "entitlement",
    "title",
    "date",
    "source"
   ],
   "rows": [],
   "rule": "A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded."
  },
  "lifecycle": {
   "delisting": [],
   "domicile_change": {
    "market": "US",
    "reason": "EDGAR states no dated change of state of incorporation on a filing line",
    "state": "not_on_record"
   },
   "listing": [],
   "name_change": [],
   "segment_move": {
    "market": "US",
    "reason": "the exchanges' tier transfers are not EDGAR filings",
    "state": "not_on_record"
   }
  },
  "market": "US",
  "node": "us-cm-kg",
  "numbers_hash": "sha256:d9dd874a48021ff33ab357b27014247211e431a3f0cc73b972432b8f85e4726b",
  "open_research": {
   "read_date": "2026-11-11",
   "rows": [],
   "state": "none_found"
  },
  "orderability": {
   "chapter_as_of": "2026-11-04",
   "client_categories": [],
   "determinable": false,
   "read": {
    "chapter": "https://mcp.us-cm-kg.ai/book/aio.json",
    "door": "https://mcp.us-cm-kg.ai/mcp",
    "tool": "get_orderability"
   },
   "reason": "the chapter's orderability section carries no client_categories: the outcome cannot name its client category",
   "rule_version": "acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1",
   "section": "us.aio.v8"
  },
  "record": {
   "as_of": "2026-11-08",
   "url": "https://mcp.us-cm-kg.ai/record/NASDAQ/SKYE",
   "version": 1
  },
  "schema": "research-numbers v0.1 (USR-01, 2026-11-11)",
  "status": {
   "read_date": "2026-11-08",
   "source": "https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts",
   "value": "listed, not halted"
  }
 },
 "numbers_hash": "sha256:d9dd874a48021ff33ab357b27014247211e431a3f0cc73b972432b8f85e4726b",
 "path": "/us/NASDAQ/SKYE",
 "schema": "research-page v0.1 (USR-02, 2026-11-11)",
 "sections": [
  {
   "id": "identity",
   "text": "The issuer is Skye Bioscience, Inc., listed on NASDAQ under the ticker SKYE. Its ISIN is not on the record and its LEI is not on the record. Its security type is Corporate, its sector is 2834 Pharmaceutical Preparations, and its jurisdiction is the United States, Nevada. Its segment is not on the record. Its status is listed, not halted.",
   "title": "Identity and listing"
  },
  {
   "id": "disclosure",
   "text": "The record holds 64 filings across 30 filing days in the window 2025-11-08 to 2026-11-08. The median gap between filing days is 8 days. The median latency is 11 days from the latest filing to the record date of 2026-11-08. The latest filing is dated 2026-10-28 and is of type regulatory_filing. The NASDAQ median is 6.0 days for cadence, 52 filings and 5.0 days for latency across 4,359 issuers. The sector median is 6.0 days for cadence, 63.0 filings and 4.0 days for latency across 526 issuers.",
   "title": "The disclosure read"
  },
  {
   "id": "auditor",
   "text": "The auditor of record is CBIZ CPAs P.C., located in Morristown, New Jersey. The record holds no auditor changes.",
   "title": "Auditor"
  },
  {
   "id": "events",
   "text": "The record holds no listing, delisting or name change lines. The domicile change is not on the record, because EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, because the exchanges' tier transfers are not EDGAR filings. The halt flag reads listed, not halted.",
   "title": "Events and halts"
  },
  {
   "id": "orderability",
   "text": "The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.",
   "title": "Orderability"
  },
  {
   "id": "coverage",
   "text": "The record names 8 research houses on the issuer's investor-relations page: Cantor Fitzgerald, Citizens JMP, Craig-Hallum Capital Group, Evercore ISI, H.C. Wainwright & Co., Oppenheimer & Co., Piper Sandler and William Blair.",
   "title": "Coverage"
  },
  {
   "id": "open_research",
   "text": "No openly published research notes were found on the record.",
   "title": "Open research"
  },
  {
   "id": "licensed",
   "text": "Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.",
   "title": "Licensed"
  },
  {
   "id": "depth",
   "text": "The sealed years that hold the issuer are 2021, 2022, 2023, 2024, 2025 and 2026. The earliest sealed date of the market is 2021-01-04. The live record began on 2026-09-12.",
   "title": "As-of depth"
  },
  {
   "id": "sources",
   "text": "8 source pages are named on this page; every value above carries its own source page and read date in the numbers.",
   "title": "Sources"
  }
 ],
 "sources": [
  {
   "for": "identity.exchange",
   "source": "https://www.sec.gov/files/company_tickers_exchange.json"
  },
  {
   "for": "identity.jurisdiction",
   "source": "https://data.sec.gov/submissions/CIK0001516551.json"
  },
  {
   "for": "the disclosure lines",
   "source": "https://mcp.us-cm-kg.ai/events/NASDAQ/SKYE"
  },
  {
   "for": "the halt flag",
   "source": "https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts"
  },
  {
   "for": "the auditor",
   "source": "https://www.sec.gov/Archives/edgar/data/1516551/000162828026016394/skye-20251231.htm"
  },
  {
   "for": "the orderability chapter",
   "source": "https://mcp.us-cm-kg.ai/book/aio.json"
  },
  {
   "for": "coverage",
   "source": "https://ir.skyebioscience.com/stock-data/analyst-coverage"
  },
  {
   "for": "the record",
   "source": "https://mcp.us-cm-kg.ai/record/NASDAQ/SKYE"
  }
 ],
 "title": "Skye Bioscience, Inc. (SKYE) — research page",
 "writer": {
  "by": "Claude through the platform account, Haiku class; one pass; checked against the numbers",
  "engine": "claude-haiku-5-5"
 }
}